Which indicates that the short term of inbitor generation is 3.3%(1/30).Conclusion Kogenate FS has better efficacy, safety and lower inhibitor generation in Chinese patients with hemophilia A.

 
  • 然而,拜科奇在中國血友病A人群中臨床使用的有效性和安全性需要更多的重復研究。
今日熱詞
目錄 附錄 查詞歷史
国内精品美女A∨在线播放xuan